Boehringer - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Boehringer Ingleheim’s Jardiance set to compete as a new therapy for heart failure

Boehringer Ingelheim and Eli Lilly post their trial results at the American Heart Association Scientific Sessions 2019.